Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence - Kute, TE; Grondahl-Hansen, J; Shao, SM (Breast Cancer Res Treat, 1998)
et al.